Publication Date:
2013-05-10
Description:
The novel c-Met inhibitor cabozantinib overcomes gemcitabine resistance and stem cell signaling in pancreatic cancer Cell Death and Disease 4, e627 (May 2013). doi:10.1038/cddis.2013.158 Authors: C Hage, V Rausch, N Giese, T Giese, F Schönsiegel, S Labsch, C Nwaeburu, J Mattern, J Gladkich & I Herr
Keywords:
cancer stem cellspancreatic cancerXL184
Electronic ISSN:
2041-4889
Topics:
Biology
,
Medicine
Permalink